[1
]
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of
Pharmacy, University of North Carolina at Chapel Hill, Kerr Hall, CB #7569, Chapel
Hill, NC, 27599, USA. bferslew@theravance.com.
[2
]
Clinical Pharmacology and Drug Metabolism and Pharmacokinetics, Theravance Biopharma
US, Inc., 901 Gateway Blvd, South San Francisco, CA, 94080, USA. bferslew@theravance.com.
[3
]
Metabolomics Shared Resource, University of Hawaii Cancer Center, 701 Ilalo Street,
Honolulu, HI, 96813, USA. GXie@cc.hawaii.edu.
[4
]
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of
Pharmacy, University of North Carolina at Chapel Hill, Kerr Hall, CB #7569, Chapel
Hill, NC, 27599, USA. curtis.k.johnston@gmail.com.
[5
]
Metabolomics Shared Resource, University of Hawaii Cancer Center, 701 Ilalo Street,
Honolulu, HI, 96813, USA. MSu@cc.hawaii.edu.
[6
]
Department of Biostatistics, UNC Gillings School of Global Public Health, University
of North Carolina at Chapel Hill, 3105G McGavran-Greenberg Hall, Chapel Hill, NC,
27599, USA. Paul_Stewart@unc.edu.
[7
]
Metabolomics Shared Resource, University of Hawaii Cancer Center, 701 Ilalo Street,
Honolulu, HI, 96813, USA. WJia@cc.hawaii.edu.
[8
]
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of
Pharmacy, University of North Carolina at Chapel Hill, Kerr Hall, CB #7569, Chapel
Hill, NC, 27599, USA. kbrouwer@unc.edu.
[9
]
Division of Gastroenterology and Hepatology, UNC School of Medicine, University of
North Carolina at Chapel Hill, 8004 Burnett Womack, CB #7584, Chapel Hill, NC, 27599-7584,
USA. sid_barritt@med.unc.edu.